Evidence map›Paper›PMID 25364714›Full record

ReviewFrontiers in cell and developmental biology2014

Olfactomedin proteins: central players in development and disease.

Robert R H Anholt

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Stabilization of OLFML1 via mInternational journal of biological sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Obesity wars: may the smell be with you.American journal of physiology. Endocrinology and metabolism · 2023
    Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robert R H AnholtDepartment of Biological Sciences and W. M. Keck Center for Behavioral Biology, North Carolina State University Raleigh, NC, USA.
North Carolina State University · US

Funding

Molecular Genetics of Olfaction in DrosophiliaR01GM059469 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI ANHOLT, ROBERT R. H, MACKAY, TRUDY F. · 1999 to 2016
$5.8M
Genetic Basis of Lifespan and Healthspan Extension by ACE Inhibition in DrosophilaR01AG073181 · NIA · CLEMSON UNIVERSITY · PI Robert R. H Anholt, MARIA DE LUCA · 2022 to 2026
$2.4M
NIA NIH HHS R01 AG073181NIGMS NIH HHS R01 GM059469
6 · The paper itself

Abstract

Olfactomedin proteins are characterized by a conserved domain of \texorpdfstring~\textasciitilde250 amino acids corresponding to the olfactomedin archetype first discovered in olfactory neuroepithelium. They arose early in evolution and occur throughout the animal kingdom. In mice and humans olfactomedin proteins comprise a diverse array of glycoproteins, many of which are critical for early development and functional organization of the nervous system as well as hematopoiesis. Olfactomedin domains appear to facilitate protein-protein interactions, intercellular interactions, and cell adhesion. Several members of the family have been implicated in various common diseases, notably myocilin in glaucoma and OLFM4 in cancer. This review highlights this important, hitherto understudied family of proteins.

Indexed as

colorectal cancerglaucomamyocilinnervous systemOLFM4

Identifiers

PMID25364714
PMCPMC4206993
OpenAlexW2000434886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.